Response-Adapted Postinduction Strategy in Follicular Lymphoma.

Shibusawa, Motoharu; Kusumi, Eiji; Murakami, Jun; Tanimoto, Tetsuya

Shibusawa, Motoharu; Kusumi, Eiji; Murakami, Jun; Tanimoto, Tetsuya.

Afiliação

Shibusawa M; Motoharu Shibusawa, MD, Shinmatsudo Central General Hospital, Department of Hematology, Chiba, Japan; Eiji Kusumi, MD, Navitas Clinic Tachikawa, Tokyo, Japan; Jun Murakami, MD, PhD, Clinical Laboratory, Transfusion Medicine and Cell Therapy Toyama University Hospital, Toyama, Japan; and Tetsuya Tani
Kusumi E; Motoharu Shibusawa, MD, Shinmatsudo Central General Hospital, Department of Hematology, Chiba, Japan; Eiji Kusumi, MD, Navitas Clinic Tachikawa, Tokyo, Japan; Jun Murakami, MD, PhD, Clinical Laboratory, Transfusion Medicine and Cell Therapy Toyama University Hospital, Toyama, Japan; and Tetsuya Tani
Murakami J; Motoharu Shibusawa, MD, Shinmatsudo Central General Hospital, Department of Hematology, Chiba, Japan; Eiji Kusumi, MD, Navitas Clinic Tachikawa, Tokyo, Japan; Jun Murakami, MD, PhD, Clinical Laboratory, Transfusion Medicine and Cell Therapy Toyama University Hospital, Toyama, Japan; and Tetsuya Tani
Tanimoto T; Motoharu Shibusawa, MD, Shinmatsudo Central General Hospital, Department of Hematology, Chiba, Japan; Eiji Kusumi, MD, Navitas Clinic Tachikawa, Tokyo, Japan; Jun Murakami, MD, PhD, Clinical Laboratory, Transfusion Medicine and Cell Therapy Toyama University Hospital, Toyama, Japan; and Tetsuya Tani

J Clin Oncol ; 40(15): 1705, 2022 05 20.

Article em En | MEDLINE | ID: mdl-35275704

Assuntos

Linfoma Folicular; Humanos; Quimioterapia de Indução; Linfoma Folicular/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google